pyridoxine and semaglutide together Semaglutide-Pyridoxine® (Vit B6) 2.5 mg-2.5 mg/ml Compounded Pyridoxine HCl Injection |

In this review, we discuss the mechanism of action of GLP-1 RAs, focusing on their proposed cardiometabolic impact and the key clinical trials that have demonstrated improvement in cardiovascular outcomes

Potter E, Marwick TH

Semaglutide generally produces faster and more consistent fat loss compared to intermittent fasting

Contraindication screening : Tirzepatide is contraindicated in personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in patients with severe hypersensitivity to tirzepatide

The Regulatory Landscape: Current Context The GLP-1 telehealth space operates in an evolving regulatory environment

In the STEP and SELECT trials ( Lancet Diabetes & Endocrinology , 2024), weight typically stabilised after an initial steep drop and then declined more slowly